Skip to main content
. 2022 Jun 22;12:926196. doi: 10.3389/fonc.2022.926196

Figure 3.

Figure 3

Kaplan–Meier curves with survival from the start of second-line treatment for responding (n = 24, in blue) and non-responding (n = 7, in purple) patients (log-rank test, p-value = 0.871). Cumulative proportion surviving at the end of the interval by a step of 50 days between the two groups.